CA4A_CONMA
ID CA4A_CONMA Reviewed; 79 AA.
AC P0C1X1;
DT 19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT 19-SEP-2006, sequence version 1.
DT 25-MAY-2022, entry version 45.
DE RecName: Full=Kappa-conotoxin-like MIVA;
DE Flags: Precursor;
OS Conus magus (Magical cone).
OC Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
OC Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Pionoconus.
OX NCBI_TaxID=6492;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 39-74, HYDROXYLATION AT
RP PRO-40; PRO-55; PRO-60; PRO-61; PRO-69; PRO-70 AND PRO-74, AMIDATION AT
RP PRO-74, GAMMA-CARBOXYGLUTAMATION AT GLU-41, AND MASS SPECTROMETRY.
RC TISSUE=Venom, and Venom duct;
RX PubMed=14701840; DOI=10.1074/jbc.m309654200;
RA Santos A.D., McIntosh J.M., Hillyard D.R., Cruz L.J., Olivera B.M.;
RT "The A-superfamily of conotoxins: structural and functional divergence.";
RL J. Biol. Chem. 279:17596-17606(2004).
CC -!- FUNCTION: Kappa-conotoxins bind and inhibit voltage-gated potassium
CC channels (By similarity). This highly potent excitatory peptide elicits
CC repetitive action potentials and causes the same spastic symptomatology
CC as kappa-conotoxin SIVA. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom duct.
CC -!- DOMAIN: The cysteine framework is IV (CC-C-C-C-C).
CC -!- PTM: Contains 3 disulfide bonds (By similarity). They are not added,
CC since framework IV presents two different connectivities (I-V, II-III,
CC IV-VI and I-III, II-V, IV-VI). {ECO:0000250}.
CC -!- MASS SPECTROMETRY: Mass=5095.3; Method=LSI;
CC Evidence={ECO:0000269|PubMed:14701840};
CC -!- SIMILARITY: Belongs to the conotoxin A superfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0C1X1; -.
DR SMR; P0C1X1; -.
DR ConoServer; 18; MIVA precursor.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0030550; F:acetylcholine receptor inhibitor activity; IEA:InterPro.
DR GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR InterPro; IPR009958; Conotoxin_a-typ.
DR Pfam; PF07365; Toxin_8; 1.
PE 1: Evidence at protein level;
KW Amidation; Direct protein sequencing; Disulfide bond;
KW Gamma-carboxyglutamic acid; Glycoprotein; Hydroxylation;
KW Ion channel impairing toxin; Neurotoxin; Potassium channel impairing toxin;
KW Secreted; Signal; Toxin.
FT SIGNAL 1..21
FT /evidence="ECO:0000255"
FT PROPEP 22..38
FT /evidence="ECO:0000269|PubMed:14701840"
FT /id="PRO_0000249800"
FT PEPTIDE 39..74
FT /note="Kappa-conotoxin-like MIVA"
FT /id="PRO_0000249801"
FT PROPEP 75..79
FT /id="PRO_0000249802"
FT MOD_RES 40
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 41
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 55
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 60
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 61
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 69
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 70
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 74
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:14701840"
FT MOD_RES 74
FT /note="Proline amide"
FT /evidence="ECO:0000269|PubMed:14701840"
FT CARBOHYD 45
FT /note="O-linked (HexNAc...) threonine"
FT /evidence="ECO:0000305"
FT CARBOHYD 47
FT /note="O-linked (HexNAc...) threonine"
FT /evidence="ECO:0000305"
SQ SEQUENCE 79 AA; 8680 MW; 46AC083059DF97CA CRC64;
MGMRMMFTVF LLVVLATTVV SIPSDRASDG RNAVVHERAP ELVVTATTNC CGYNPMTICP
PCMCTYSCPP KRKPGRRND